Royal Bank of Canada’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-315
Closed 7249
2023
Q3
$0 Sell
315
-12,295
-98% ﹤0.01% 7242
2023
Q2
$4K Buy
12,610
+1,779
+16% +$564 ﹤0.01% 6304
2023
Q1
$5K Buy
10,831
+10,631
+5,316% +$4.91K ﹤0.01% 6205
2022
Q4
$0 Sell
200
-2,068
-91% ﹤0.01% 7394
2022
Q3
$2K Buy
+2,268
New +$2K ﹤0.01% 6612
2022
Q2
Sell
-3,925
Closed -$8K 7335
2022
Q1
$8K Buy
+3,925
New +$8K ﹤0.01% 6592
2021
Q4
Sell
-2,170
Closed -$9K 7365
2021
Q3
$9K Sell
2,170
-3,353
-61% -$13.9K ﹤0.01% 6489
2021
Q2
$29K Sell
5,523
-8,706
-61% -$45.7K ﹤0.01% 5874
2021
Q1
$66K Buy
14,229
+13,729
+2,746% +$63.7K ﹤0.01% 5230
2020
Q4
$2K Sell
500
-40,608
-99% -$162K ﹤0.01% 6333
2020
Q3
$136K Sell
41,108
-701
-2% -$2.32K ﹤0.01% 4330
2020
Q2
$141K Sell
41,809
-15,928
-28% -$53.7K ﹤0.01% 4195
2020
Q1
$220K Buy
57,737
+6,437
+13% +$24.5K ﹤0.01% 3795
2019
Q4
$310K Buy
51,300
+10,494
+26% +$63.4K ﹤0.01% 3745
2019
Q3
$308K Sell
40,806
-3,170
-7% -$23.9K ﹤0.01% 3614
2019
Q2
$596K Buy
43,976
+3,530
+9% +$47.8K ﹤0.01% 3221
2019
Q1
$219K Buy
40,446
+20,262
+100% +$110K ﹤0.01% 3765
2018
Q4
$60K Sell
20,184
-35,635
-64% -$106K ﹤0.01% 4345
2018
Q3
$438K Buy
55,819
+54,467
+4,029% +$427K ﹤0.01% 3419
2018
Q2
$13K Sell
1,352
-2,998
-69% -$28.8K ﹤0.01% 5158
2018
Q1
$37K Sell
4,350
-1,190
-21% -$10.1K ﹤0.01% 4591
2017
Q4
$70K Buy
5,540
+2,652
+92% +$33.5K ﹤0.01% 4289
2017
Q3
$24K Buy
2,888
+2,780
+2,574% +$23.1K ﹤0.01% 5116
2017
Q2
$2K Buy
108
+106
+5,300% +$1.96K ﹤0.01% 5549
2017
Q1
$0 Sell
2
-98
-98% ﹤0.01% 6031
2016
Q4
$2K Buy
+100
New +$2K ﹤0.01% 5724
2015
Q4
Sell
-100
Closed -$1K 6053
2015
Q3
$1K Buy
+100
New +$1K ﹤0.01% 5930